Drug intelligence / Profile preview

FJZHT03

Development stage
Unknown
Lead developer
Jilin Academy of Chinese Medicine Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

FJZHT03 is a Traditional Chinese Medicine (TCM) formulation developed by the Changchun University of Chinese Medicine (formerly Changchun Traditional Chinese Medicine College) specifically for the treatment of stable angina pectoris. As a multi-component herbal preparation, it is designed to address the underlying pathology of coronary heart disease by invigorating blood circulation and resolving blood stasis. Pharmacological studies indicate that FJZHT03 exerts its therapeutic effects by inhibiting platelet aggregation, reducing blood viscosity, and improving myocardial blood supply. It is typically administered orally and has been evaluated in clinical trials in China for its ability to reduce the frequency of anginal attacks and improve electrocardiographic parameters in patients with stable coronary artery disease.

Other names
FJZHT03 capsuleFJZHT-03 capsuleFJZHT 03 capsule
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on FJZHT03.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FJZHT03.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call